Full name
POLPHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
47.51.Z - Retail sale of textile products
47.71.Z - Retail sale of clothing
47.72.Z - Retail sale of footwear and leather goods
47.75.Z - Retail sale of cosmetics and toiletries
47.77.Z - Retail sale of watches and jewelry
96.02.Z - Individual service activities
96.09.Z - Individual service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -75,9 | |||
Gross profit (loss) | -0,2 | 0,2 | 0 | -86 |
EBITDA | -0,2 | 0 | 0,1 | 40,7 |
Short time liabilities | 0,7 | 0,7 | 0,9 | 24,9 |
Other operating costs | -33,6 | |||
Equity capital | 0,6 | 0,8 | 0,8 | 2,5 |
Operating profit (EBIT) | -0,2 | 0 | 0 | 98,8 |
Assets | 1,3 | 1,4 | 1,6 | 13,3 |
Net profit (loss) | -0,2 | 0,2 | 0 | -87,5 |
Cash | 0,5 | 0,7 | 0,8 | 9,7 |
Net income from sale | 3 | 3,5 | 3,3 | -4,9 |
Liabilities and provisions for liabilities | 0,7 | 0,7 | 0,9 | 25,3 |
Working assets | 0,8 | 1 | 1,2 | 22,5 |
Other income costs | -11,9 | |||
Depreciation | 0 | 0 | 0 | -27,3 |
% | % | % | p.p. | |
Profitability of capital | -25,5 | 20,2 | 2,5 | -17,7 |
Equity capital to total assets | 45,3 | 52,6 | 47,6 | -5 |
Gross profit margin | -5,1 | 4,4 | 0,6 | -3,8 |
EBITDA Margin | -5,8 | 1,2 | 1,8 | 0,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 88 | 72 | 94 | 22 |
Current financial liquidity indicator | 1.049639105796814 | 1.389691710472107 | 1.3629719018936157 | 0 |
Net dept to EBITDA | 1.1684796810150146 | -13.659087181091309 | -9.300261497497559 | 4,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane